BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 26552432)

  • 1. Abbreviated protocol of plasma exchanges for patients with anti-factor H associated hemolytic uremic syndrome.
    Thangaraju S; Khandelwal P; Mishra K; Kumar M; Puraswani M; Saini R; Hari P; Coshic P; Sinha A; Bagga A
    Pediatr Nephrol; 2024 Jan; ():. PubMed ID: 38270601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of plasma exchange in ANCA-associated vasculitis.
    Pimentel-Quiroz VR; Alarcón GS
    Lancet Rheumatol; 2023 Oct; 5(10):e579-e580. PubMed ID: 38251481
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasma exchange for the management of digoxin toxicity in an individual with an acute kidney injury: A case report.
    Preston H; Cannon E; Watson S
    J R Coll Physicians Edinb; 2024 Mar; 54(1):55-58. PubMed ID: 38499459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffuse Alveolar Hemorrhage Secondary to Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Predictors of Respiratory Failure and Clinical Outcomes.
    Cartin-Ceba R; Diaz-Caballero L; Al-Qadi MO; Tryfon S; Fervenza FC; Ytterberg SR; Specks U
    Arthritis Rheumatol; 2016 Jun; 68(6):1467-76. PubMed ID: 26713723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spotlight on rituximab in the treatment of antineutrophil cytoplasmic antibody-associated vasculitis: current perspectives.
    Moog P; Thuermel K
    Ther Clin Risk Manag; 2015; 11():1749-58. PubMed ID: 26664125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systematic literature review informing the 2022 update of the EULAR recommendations for the management of ANCA-associated vasculitis (AAV): part 1-treatment of granulomatosis with polyangiitis and microscopic polyangiitis.
    Schirmer JH; Sanchez-Alamo B; Hellmich B; Jayne D; Monti S; Luqmani RA; Tomasson G
    RMD Open; 2023 Jul; 9(3):. PubMed ID: 37479496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term outcomes in elderly patients with ANCA-associated vasculitis.
    McGovern D; Williams SP; Parsons K; Farrah TE; Gallacher PJ; Miller-Hodges E; Kluth DC; Hunter RW; Dhaun N
    Rheumatology (Oxford); 2020 May; 59(5):1076-1083. PubMed ID: 31794032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclophosphamide-Induced Lung Injury.
    Pugh D; Farrah TE; Gallacher PJ; Kluth DC; Dhaun N
    Kidney Int Rep; 2019 Mar; 4(3):484-486. PubMed ID: 30899875
    [No Abstract]   [Full Text] [Related]  

  • 9. Recurrence of anti-neutrophil cytoplasmic antibody vasculitis in the kidney allograft.
    Lau D; Summers S; Amos L; Simpson I; Mulley W
    Nephrology (Carlton); 2012 Apr; 17 Suppl 1():16-9. PubMed ID: 22497649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal transplantation in anti-neutrophil cytoplasmic antibody-associated vasculitis.
    Hruskova Z; Geetha D; Tesar V
    Nephrol Dial Transplant; 2015 Apr; 30 Suppl 1():i159-63. PubMed ID: 25324359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefits of an expanded use of plasma exchange for anti-neutrophil cytoplasmic antibody-associated vasculitis within a dedicated clinical service.
    Dhaun N; Saunders A; Bellamy CO; Gallardo RM; Manson L; Kluth DC
    BMC Musculoskelet Disord; 2015 Nov; 16():343. PubMed ID: 26552432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma Exchange Is Highly Effective for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Patients With Rapidly Progressive Glomerulonephritis Who Have Advanced to Dialysis Dependence: A Single-Center Case Series.
    Nishida R; Kaneko S; Usui J; Kawamura T; Tsunoda R; Tawara T; Fujita A; Nagai K; Kai H; Morito N; Saito C; Yamagata K
    Ther Apher Dial; 2019 Jun; 23(3):253-260. PubMed ID: 31033151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of severe renal disease in ANCA positive and negative small vessel vasculitis with rituximab.
    Shah S; Hruskova Z; Segelmark M; Morgan MD; Hogan J; Lee SK; Dale J; Harper L; Tesar V; Jayne DR; Geetha D
    Am J Nephrol; 2015; 41(4-5):296-301. PubMed ID: 26044574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early plasma exchange improves outcome in PR3-ANCA-positive renal vasculitis.
    Gregersen JW; Kristensen T; Krag SR; Birn H; Ivarsen P
    Clin Exp Rheumatol; 2012; 30(1 Suppl 70):S39-47. PubMed ID: 22510451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcome of patients with ANCA-associated vasculitis treated with plasma exchange: a retrospective, single-centre study.
    Frausová D; Hrušková Z; Lánská V; Lachmanová J; Tesař V
    Arthritis Res Ther; 2016 Jul; 18():168. PubMed ID: 27412443
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.